Physician profile
Mark E Zolman
NPI 1467455436
$2,239.66
in general payments reported to CMS, 2019-2025
19 companies · $163 in 2025
The $163 reported for 2025 was more than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $186 · 2020: $1,151 · 2021: $392 · 2022: $190 · 2023: $142 · 2024: $14.65 · 2025: $163.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $320.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $319.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $821.42 | 2020-2021 | |
| Stimwave Technologies Incorporated | $378.54 | 2020 | |
| Medtronic, INC. | $229.76 | 2021-2025 | Synchromedii, Intellis Adaptivestim |
| Collegium Pharmaceutical, INC. | $147.57 | 2019-2021 | |
| Abbvie INC. | $137.56 | 2022-2023 | Botox |
| Tersera Therapeutics LLC | $108.81 | 2019-2020 | |
| Depuy Synthes Sales INC. | $58.92 | 2022 | |
| Allergan, INC. | $53.28 | 2019-2020 | |
| Pfizer INC. | $45.28 | 2019-2021 | |
| Ibsa Pharma INC. | $38.30 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $31.32 | 2021 | |
| Painteq LLC | $29.38 | 2023 | Painteq |
| Zyla Life Sciences, INC. | $28.05 | 2019 | |
| Bioventus LLC | $28.02 | 2022 | |
| Medtronic USA, INC. | $26.76 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Redhill Biopharma INC. | $23.04 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $20.91 | 2021 | |
| Arbor Pharmaceuticals, INC. | $18.30 | 2021 | |
| Grt US Holding, INC. | $14.44 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Zolman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.